Thus, considering the changes in GLUT1 expression at the BBB and resulting impact on brain metabolism in AD, and the increased sensitivity of AD patients to antipsychotic drugs including risperidone and amisulpride, we wanted to explore the interaction between GLUT1 and amisulpride. Here, SLC2A1 is linked to Alzheimer disease.